Chlorine in PDB 6omu: Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib

Enzymatic activity of Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib

All present enzymatic activity of Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib:
2.7.10.2;

Protein crystallography data

The structure of Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib, PDB code: 6omu was solved by I.Mochalkin, A.S.Gardberg, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 22.00 / 1.41
Space group P 21 21 2
Cell size a, b, c (Å), α, β, γ (°) 72.173, 104.520, 37.983, 90.00, 90.00, 90.00
R / Rfree (%) 19 / 22.6

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib (pdb code 6omu). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib, PDB code: 6omu:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 6omu

Go back to Chlorine Binding Sites List in 6omu
Chlorine binding site 1 out of 2 in the Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl701

b:14.1
occ:0.50
O A:HOH1075 2.3 28.2 1.0
O A:HOH1077 2.9 15.9 1.0
N A:ALA478 2.9 7.4 1.0
O A:TYR476 3.1 8.8 1.0
N A:ASP531 3.2 8.0 1.0
CB A:ALA478 3.4 8.7 1.0
CB A:ASN530 3.4 6.1 1.0
CA A:ASN530 3.5 5.4 1.0
CA A:MET477 3.7 6.6 1.0
CA A:ALA478 3.7 8.1 1.0
C A:MET477 3.8 6.8 1.0
C A:ASN530 3.8 6.8 1.0
O A:HOH839 3.9 25.8 1.0
C A:TYR476 4.0 7.9 1.0
OD1 A:ASP531 4.0 16.3 1.0
CG A:ASP531 4.0 12.4 1.0
CB A:ASP531 4.0 9.7 1.0
CA A:ASP531 4.2 8.5 1.0
O A:HOH878 4.2 23.0 1.0
N A:MET477 4.2 6.2 1.0
O A:HOH909 4.4 20.5 1.0
O A:HOH1038 4.5 24.7 1.0
CG A:ASN530 4.6 7.1 1.0
OD2 A:ASP531 4.6 18.8 1.0
CD2 A:TYR476 4.6 10.8 1.0
O A:HOH947 4.6 19.1 1.0
C A:ALA478 4.9 8.6 1.0
N A:ASN530 4.9 5.0 1.0
CE2 A:TYR476 4.9 12.0 1.0
O A:ASN530 5.0 6.6 1.0
CB A:MET477 5.0 7.1 1.0
O A:MET477 5.0 7.8 1.0
N A:ASN479 5.0 7.8 1.0
O A:VAL529 5.0 5.3 1.0

Chlorine binding site 2 out of 2 in 6omu

Go back to Chlorine Binding Sites List in 6omu
Chlorine binding site 2 out of 2 in the Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Structure of Human Bruton'S Tyrosine Kinase in Complex with Evobrutinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl701

b:19.8
occ:0.50
O A:HOH839 2.6 25.8 1.0
O A:ASP426 2.8 11.0 1.0
N A:TYR476 2.9 7.5 1.0
O A:HOH980 3.4 27.8 1.0
CA A:GLU475 3.5 9.6 1.0
OH A:TYR461 3.6 18.7 1.0
C A:ASP426 3.6 10.1 1.0
C A:GLU475 3.6 8.9 1.0
O A:HOH878 3.7 23.0 1.0
CB A:TYR476 3.7 7.6 1.0
CA A:TYR476 3.8 7.6 1.0
CB A:ASP426 3.9 9.7 1.0
CG A:GLU475 4.0 12.3 1.0
CB A:GLU475 4.1 11.6 1.0
O A:TYR476 4.2 8.8 1.0
O A:HOH909 4.3 20.5 1.0
CA A:ASP426 4.4 10.8 1.0
CE2 A:TYR461 4.4 14.9 1.0
N A:VAL427 4.5 9.1 1.0
O A:HOH1206 4.5 32.7 1.0
CZ A:TYR461 4.5 16.3 1.0
C A:TYR476 4.5 7.9 1.0
CA A:VAL427 4.6 8.0 1.0
N A:GLU475 4.7 8.9 1.0
O A:THR474 4.7 8.2 1.0
O A:GLU475 4.9 8.4 1.0
N A:ASP426 4.9 11.8 1.0

Reference:

R.D.Caldwell, H.Qiu, B.C.Askew, A.T.Bender, N.Brugger, M.Camps, M.Dhanabal, V.Dutt, T.Eichhorn, A.S.Gardberg, A.Goutopoulos, R.Grenningloh, J.Head, B.Healey, B.L.Hodous, B.R.Huck, T.L.Johnson, C.Jones, R.C.Jones, I.Mochalkin, F.Morandi, N.Nguyen, M.Meyring, J.R.Potnick, D.C.Santos, R.Schmidt, B.Sherer, A.Shutes, K.Urbahns, A.V.Follis, A.A.Wegener, S.C.Zimmerli, L.Liu-Bujalski. Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton'S Tyrosine Kinase (Btk) Inhibitor For the Treatment of Immunological Diseases. J.Med.Chem. V. 62 7643 2019.
ISSN: ISSN 0022-2623
PubMed: 31368705
DOI: 10.1021/ACS.JMEDCHEM.9B00794
Page generated: Sat Dec 12 13:27:16 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy